D’Agati, V. D., Alster, J. M., Jennette, J. C., Thomas, D. B., Pullman, J., Savino, D. A., … Nast, C. C. (2013). Association of Histologic Variants in FSGS Clinical Trial with Presenting Features and Outcomes. Clinical Journal of the American Society of Nephrology, 8(3), 399–406. https://doi.org/10.2215/cjn.06100612

D’Agati, Vivette D., Joan M. Alster, J Charles Jennette, David B. Thomas, James Pullman, Daniel A. Savino, Arthur H. Cohen, et al. “Association of Histologic Variants in FSGS Clinical Trial with Presenting Features and Outcomes.” Clinical Journal of the American Society of Nephrology 8, no. 3 (March 2013): 399–406. https://doi.org/10.2215/cjn.06100612.

D’Agati VD, Alster JM, Jennette JC, Thomas DB, Pullman J, Savino DA, et al. Association of Histologic Variants in FSGS Clinical Trial with Presenting Features and Outcomes. Clinical Journal of the American Society of Nephrology. 2013 Mar;8(3):399–406.

D’Agati, Vivette D., et al. “Association of Histologic Variants in FSGS Clinical Trial with Presenting Features and Outcomes.” Clinical Journal of the American Society of Nephrology, vol. 8, no. 3, Ovid Technologies (Wolters Kluwer Health), Mar. 2013, pp. 399–406. Crossref, doi:10.2215/cjn.06100612.

D’Agati VD, Alster JM, Jennette JC, Thomas DB, Pullman J, Savino DA, Cohen AH, Gipson DS, Gassman JJ, Radeva MK, Moxey-Mims MM, Friedman AL, Kaskel FJ, Trachtman H, Alpers CE, Fogo AB, Greene TH, Nast CC. Association of Histologic Variants in FSGS Clinical Trial with Presenting Features and Outcomes. Clinical Journal of the American Society of Nephrology. Ovid Technologies (Wolters Kluwer Health); 2013 Mar;8(3):399–406.